跳至主要内容
临床试验/NL-OMON25689
NL-OMON25689招募中不适用

Offering hrHPV testing on self-sampled cervicovaginal specimens to women who are non-responder in the conventional cervical screening program.

VU University Medical Center, Department of Pathology, Amsterdam, The Netherlands; IKA (Comprehensive Cancer Center Amsterdam);RIVM (National Institute of Public Health and Environmental Protection)0 个研究点目标入组 45,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
45,000

研究概览

简要总结

Brink et al. J Clin Microbiol. 2006; 44:2518-23. Bais et al. Int. J. Cancer submitted

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Women invited for the cervical cancer screening program (ages 30-60 years), but who are not responding to their invitation as well as their recall (3 months after);
  • 2. Residing in the region covered by district health authorities of North Holland and Flevoland (in the Netherlands).

排除标准

  • 1. Not called for screening, i.e., ages under 30 years, or over 60 years;
  • 2. Actively responded to the invitation or first recall of the cervical screening program by undergoing a cervical smear at the general practitioner;
  • 3. Living outside the region covered by district health authorities of North Holland and Flevoland;
  • 4. Under follow-up by gynaecologist for previous non-normal cytology, i.e., abnormal cytology and/or CIN3 lesion or worse less than 2 years before inclusion;
  • 5. Current pregnancy;
  • 6. Status after extirpation of the uterus or amputation of the portio.

研究者

发起方
VU University Medical Center, Department of Pathology, Amsterdam, The Netherlands; IKA (Comprehensive Cancer Center Amsterdam);RIVM (National Institute of Public Health and Environmental Protection)

相似试验